Supporting research excellence through funding and grant opportunities.
BRC Grants
Lilly George Travel Award (Launched January 2024)
In honour of Mrs. Lily George, this award will assist budding neuroscientists, who are senior level Dalhousie undergraduates in neuroscience, psychology, or biochemistry by providing funding to travel to a brain-related science conference in Canada or the USA. The award can be used for, but not limited to, the cost of registration, transport, accommodation, and food in accordance with department criteria.
The recipient will have demonstrated research excellence, intellectual, curiosity, originality, and rigor, and will show promise to become an independent researcher. Furthermore, the recipient should be a good communicator, both in oral settings and in written work, and should value cooperation and collegial interaction.
Call for 2024 applications is now closed.
In 2013, we introduced funding for Knowledge Translation (KT), Research Dissemination & Commercialization (RD&C), and Discovery (D). Since then, we have awarded $270,000, which in addition to funding specific research projects, has leveraged additional funds by those researchers in excess of $3 million.
In late 2022, the KT grant program was modified and renamed as the Innovation Grant program.
Innovation Grants (formerly KT grants)
The BRC Innovation Grant Program is designed to move discoveries and inventions along the path to commercialization — with a view to attract new investment, create new neuroscience-based businesses, organizations and initiatives and to improve neurological health outcomes for Nova Scotians and Canadians. It provides funding for example, for proof-of-principle, pre-commercialization research projects, market research.
Click here for a list of KT/Innovation Grant program recipients.
*Call for Submissions will open in October 2024.
Research Dissemination & Commercialization (RD&C) Grants
The RD&C Grant Program supports events and meetings that are international in nature, that contribute to the dissemination, exchange and commercialization of research aimed at improving brain and neurological health outcomes for Nova Scotians and Canadians.
Click here for a list of RD&C Grant program recipients.
*Call for Submissions 2024 is now closed - click here for details.
Discovery Grants
The Brain Repair Centre Discovery (BRC-D) Grant was designed to stimulate creative ideas and innovative research projects with the potential to generate important new discoveries. Funding was provided by the QEII Foundation in 2016 to allow successful applicants to pursue answers to clinically-relevant neuroscience questions so that findings may be applied to improve brain health and neurological outcomes for Nova Scotians and Canadians.
In order for future Discovery Grants to be awarded, the BRC requires funding or sponsorship. For more information about how you can support the future of the BRC-D Grant Program, contact Eleanor Seaman-Bolton.
2022 DMRF Graduate Studentships for Medical Neuroscience Research
The 2022 DMRF Graduate Studentships for Medical Neuroscience Research were awarded to support trainees in the Brain Repair Centre in pursuit of a MSc or PhD degree, whose research falls under the umbrella of neuroscience. Candidates were expected to show high potential for future research achievement and productivity. Funding was made possible by DMRF and five trainees received awards starting in September 2022.
Other Grants (non-BRC)
CABHI IGNITE
The Centre for Aging + Brain Health Innovation (CABHI) understands the critical hurdles early-stage Canadian innovators (including researchers, point-of-care staff, and companies) face when designing solutions for older persons.
Early-stage innovators have limited access to funding, face high development costs, and encounter challenges with validating their solutions in real-world settings. These challenges can stall innovation progress and prevent promising ideas from achieving real-world impact.
The Ignite program is designed to target these challenges by offering early-stage Canadian innovators a range of $50,000 to $150,000 CAD in funding and additional supports to help develop, test, and validate their solutions.
Applications Close: Monday, December 2, 2024
Finalist Notifications: Monday, December 23, 2024
Announcement of Results: Monday, January 27, 2025
Full details at CABHI.com/ignite
EUREKA Canada call for projects summer-autumn 2024
The National Research Council Canada (NRC) has allocated funding for organisations collaborating on international R&D projects in all technological fields.
Closing Date: 31 October 2024.
Your project consortium must include at least one Canadian SME and an organisation based in one of the Eureka member countries/regions.
Details at eurekanetwork.org
The Alzheimer Society of Canada Research Program
Together with the Alzheimer Society of Canada (ASC), Brain Canada is excited to announce the launch of the 2024-2025 Alzheimer Society Research Program (ASRP) competition.
The ASRP provides grants and awards to support research in Canada that promises new insights into causes, risk reduction, diagnosis, treatment and management of Alzheimer’s disease and other dementias. Brain Canada and ASC will be co-funding the following grants:
New Investigator Operating Grants are designed to help launch the careers of outstanding researchers who are within the first six (6) years of their initial academic appointment. The ASRP will provide up to $200,000 for a period of up to four (4) years. Brain Canada Foundation will co-fund up to two (2) successful applications.
Proof of Concept Grants are designed to fund innovative, potentially high-risk, and high-reward research that pushes the boundaries of our existing understanding of dementia. The ASRP will provide up to $100,000 for a period of up to three (3) years. Brain Canada Foundation will co-fund up to twelve (12) successful applications.
Read the full ASRP guidelineshere.
Results will be announced in the spring of 2025, and funding will be dispersed starting in the summer of 2025.
Application Deadline:November 4, 2024, at 5:00 PM EST
Please note that applications to the Proof-of-Concept Grants were pre-screened through the submission of a Letter of Intent (LOI). The deadline to submit an LOI was July 24th, 2024, and only applicants who were invited to submit a Full Application are eligible to do so at this stage.
Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.
Should you have any questions, please contactresearch@alzheimer.ca
This program has been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) Brain Canada Foundation, and Alzheimer Society of Canada.
Brain Health Medicines
The Brain Health Medicines Scholar Award provides funding and drug development support to researchers whose work aims to treat, prevent or cure Alzheimer's disease and related dementias. The award includes:
One-year grant
$100,000 with appropriate justification
Potential to renew for a second year based on milestones achieved
Dedicated Project Manager for the duration of the award
Drug development, commercial strategy and business development support from Harrington's Therapeutics Development Center experts
Opportunity to quality for up to $400,000 in additional funding and drug development support
PROPOSALS OF INTEREST
• Novel approaches to treat Alzheimer’s Disease
• Discoveries demonstrating rigorous science, creativity, innovation, and potential for clinical impact
• Any therapeutic modality
• Novel, validated targetsIMPORTANT DATES
Applications can be submitted at any time and will be reviewed on a quarterly basis. Deadlines to submit an application for review are March 31, June 30, September 30 and December 31 annually.
2024 Q3 Application Deadline: September 30, 2024
2024 Q4 Application Deadline: December 31, 2024
More details at https://www.harringtondiscovery.org/funding/brain-health-medicines